Chiropractors in Rialto, CA Accepting Medicare

8 Chiropractors found. Showing 1 - 8

Aaron Anucherebom Ajoku, D.C., Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 263 W Rialto Ave, Rialto, CA 92376 Phone: 909-820-3130    Fax: 951-248-0982

Dr. Vinicio Cornejo, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 237 N Riverside Ave, Rialto, CA 92376 Phone: 909-874-6640    Fax: 760-241-2100

Cornejo Chiropractic, Inc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 237 N Riverside Ave, Rialto, CA 92376 Phone: 909-874-6640

Dr. Robert Bruce Parkinson, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 877 S Vine Ave, Rialto, CA 92376 Phone: 909-820-3133

Bozena Grazyna Janczar, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1850 N Riverside Ave, 220, Rialto, CA 92376 Phone: 909-421-3003    Fax: 906-421-3092

Advanced Care Chiropractic Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1613 S Riverside Ave, Ste. D, Rialto, CA 92376 Phone: 909-820-2220

Benigno Antonio Salazar, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1734 N. Riverside Ave., Suite 6, Rialto, CA 92376 Phone: 909-873-8188    Fax: 909-873-9871

Thy Khanh Nguyen, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1613 S Riverside Ave, Suite D, Rialto, CA 92376 Phone: 909-820-2220    Fax: 909-820-2224

News Archive

Indian health service contemplates its role in health care reform

Indian Country Times reports on the Indian Health Service's role in national health care reform with IHS Director Dr. Yvette Roubideaux arguing that things are improving at IHS, but the agency must adapt to rapid changes in national health care reform and demonstrate willingness to improve.

UNICEF appealing for $6M to continue water treatment in Zimbabwe

UNICEF on Wednesday said it needs $6 million to continue treating water in Zimbabwe, which does not have the funds to do it on its own, Deutsche Presse-Agentur/M&C reports.

Saladax increases claims in immunoassay space to 15 patents

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today that it has been issued six patents within the last 12 months, bringing the company's total to 15 issued U.S. patents, all of which contain broad claims in the immunoassay space.

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.

Intervals between lung cancer diagnosis and treatment may attribute to health care discrepancies

Research published in the November 2009 issue of the Journal of Thoracic Oncology has found that intervals between lung cancer suspicion, diagnosis and treatment may be attributed to health care system discrepancies.

Read more Medical News

› Verified 5 days ago